Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c

Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Increasing unusual put volume: OCUL IRM ALOY DFTX WY CIA ATAI WGMI ROST SLS EQX CRWG MUU CAVA BURL D NBIG ZSL
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery